IOBT
IO Biotech, Inc.Company Information
- Company Name
- IO Biotech, Inc.
- CIK
- CIK0001865494
- Category
- <br>Emerging growth company
- Ticker: Exchange
- IOBT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IOBT
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-05-30
- Last sale
- 2024-07-26
- Shares purchased (TTM)
- 81,100
- Shares sold (TTM)
- 23,478
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 7,829,105
- Shares outstanding
- 66,941,964
- Ownership
- 11.70%
Earnings Market Reaction
- Filing date
- 2025-11-14
- Price on filing date
- —
- 1-month reaction
- -15.82%
- 3-month reaction
- -64.95%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 31 | 28 | 37 | 60 | 80 | 101 | 118 | 143 | 166 | 110 | 129 | 143 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 11 | 5 | 5 | 6 | 7 | 6 | 4 | 3 | 3 | 4 | 6 | ||||||
| Assets Current | 37 | 39 | 42 | 65 | 86 | 108 | 124 | 147 | 168 | 113 | 132 | 148 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | ||||||
| Assets Noncurrent | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 4 | 5 | 5 | 4 | ||||||
| Assets | 40 | 42 | 46 | 68 | 90 | 111 | 128 | 151 | 173 | 118 | 137 | 152 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 7 | 4 | 4 | 4 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 12 | 14 | 12 | 14 | 10 | 8 | 7 | 11 | 6 | 6 | 6 | 6 | ||||||
| Liabilities Current | 18 | 20 | 18 | 19 | 16 | 14 | 11 | 16 | 13 | 11 | 10 | 11 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Long Term Debt Noncurrent | 17 | 7 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 21 | 21 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 39 | 41 | 19 | 21 | 17 | 15 | 13 | 18 | 15 | 13 | 13 | 13 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 424 | 416 | 415 | 413 | 411 | 410 | 408 | 407 | 405 | 330 | 329 | 327 | ||||||
| Retained Earnings Accumulated Deficit | -416 | -408 | -382 | -359 | -328 | -304 | -283 | -264 | -238 | -216 | -195 | -178 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -7 | -7 | -7 | -7 | -11 | -10 | -9 | -10 | -10 | -10 | -10 | -10 | ||||||
| Stockholders Equity | 1 | 2 | 26 | 47 | 73 | 96 | 115 | 133 | 158 | 105 | 124 | 139 | ||||||
| Liabilities And Stockholders Equity | 40 | 42 | 46 | 68 | 90 | 111 | 128 | 151 | 173 | 118 | 137 | 152 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 70 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 29 | 29 | 29 | ||||||
| Shares Outstanding | 70 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 29 | 29 | 29 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIO Biotech, Inc. (IOBT) — SEC Financial Statements & Analysis
IO Biotech, Inc. (IOBT) is a pharmaceutical preparations company, incorporated in DE. IO Biotech, Inc. trades on Nasdaq as: IOBT. IO Biotech, Inc. (IOBT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-14. Based on that filing, On profitability, IO Biotech, Inc. posts a Return on Equity (ROE) of -240.48% and a Return on Assets (ROA) of -136.03%. Per share, it reports EPS of $-1.32, diluted EPS of $-1.32, free cash flow per share of $-1.21, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -2.20% year-over-year and EPS growth of -3.75% year-over-year. On the balance sheet, it maintains a current ratio of 2.01x, a quick ratio of 1.67x, working capital of $18.52M, a debt-to-equity ratio of 42.86x, a debt ratio of 0.98, an interest coverage ratio of -83648.00x, free cash flow of $-81.06M (TTM), and net debt of $-14.00M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-1.32
- ROE TTM
- -240.48%
- ROA TTM
- -136.03%
- Debt To Equity
- 42.86x
- Free Cash Flow TTM
- $-81.06M
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IO Biotech, Inc. in?
IO Biotech, Inc. (IOBT) operates in the Pharmaceutical Preparations industry.
What exchange does IOBT trade on?
IO Biotech, Inc. (IOBT) trades on the Nasdaq.
Where is IO Biotech, Inc. incorporated?
IO Biotech, Inc. is incorporated in DE.
When was IO Biotech, Inc. (IOBT)'s most recent SEC filing?
IO Biotech, Inc. (IOBT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-14.
What is IOBT's EPS (earnings per share)?
IO Biotech, Inc. (IOBT)'s trailing twelve month EPS is $-1.32 as of 2025-09-30.
What is IOBT's ROE (return on equity)?
IO Biotech, Inc. (IOBT)'s trailing twelve month Return on Equity (ROE) is -240.48% as of 2025-09-30.
What is IOBT's ROA (return on assets)?
IO Biotech, Inc. (IOBT)'s trailing twelve month Return on Assets (ROA) is -136.03% as of 2025-09-30.